A newly identified allelic mutation c.110C>T in the CTNNB1 gene in diffuse adenomyosis among young women—a report of two cases

In: Gynecology and Pelvic Medicine · 2025 · vol. 8 , pp. 16 · doi:10.21037/gpm-24-42 · PMID:42211902 · PMC13215120 · W4411744024
article OA: gold CC0
AI-generated summary by claude@2026-06, 2026-06-08

This report identifies a novel c.110C>T mutation in the CTNNB1 gene in two young women with diffuse adenomyosis, finding β-catenin localized to the cell membrane.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-08

This case report studied two young women with severe diffuse adenomyosis, using ultrasound/CT and surgical pathology to confirm diagnosis, followed by next-generation sequencing of uterine tissue. NGS identified the same newly reported CTNNB1 allelic mutation, c.110C>T (p.S37F in exon 3, EX3), in both patients, with no other gene mutations detected, and immunohistochemistry/immunofluorescence showed β-catenin staining restricted to the cell membrane. A major caveat is that the evidence is limited to two cases and does not include functional assays to determine how the mutation contributes to disease. Relevance to endometriosis: the paper discusses genetic and molecular alterations in adenomyosis in relation to overlapping mutational profiles reported in endometriosis, including shared features such as KRAS/PIK3CA patterns in some patients, though its primary focus is diffuse adenomyosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Background: mutation site that has not been reported before. Case Description: (EX3 c.110C>T p.S37F) gene mutation at the same site. Immunohistochemical detection of β-catenin revealed cell membrane staining, and immunofluorescence also confirmed that β-catenin staining was localized to the cell-membrane. The surgery alleviated their symptoms and improved their quality of life. Up to now, no other adverse symptoms have been observed during follow-up. Conclusions: gene in diffuse AM among young women. The new discovery is expected to provide a new perspective for the pathogenesis and molecular pathology research of AM.

My notes (saved in your browser only)

Outcome instruments

MUSA

Condition tags

adenomyosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK